AQN three-lens brief
Evidence-based stock research on AQN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 11.1pp over 30 days. · Negative free cash flow last quarterly (-$181.59M).
- Outperforming SPY by 11.1pp over 30 days.
- Negative free cash flow last quarterly (-$181.59M).
- Reported earnings on 2026-11-06.
AQN closed at $5.57 (-1.24%) as of 2026-11-12. Market cap: $4.29B. P/E (trailing) 24.2. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 11.1pp over 30 days.. Concerns: negative free cash flow last quarterly (-$181.59M).. Last quarter: Revenue $642.50M, net income $57.00M, free cash flow -$181.59M.
Why three lenses on AQN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AQN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AQN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AQN brief"></iframe>